Peter Kulmburg

1.5k total citations
32 papers, 1.2k citations indexed

About

Peter Kulmburg is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Peter Kulmburg has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Peter Kulmburg's work include Immunotherapy and Immune Responses (12 papers), Virus-based gene therapy research (10 papers) and CAR-T cell therapy research (8 papers). Peter Kulmburg is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Virus-based gene therapy research (10 papers) and CAR-T cell therapy research (8 papers). Peter Kulmburg collaborates with scholars based in Germany, France and Austria. Peter Kulmburg's co-authors include Martine Mathieu, B. Félenbok, Celia E. A. Dowzer, Joseph F. Kelly, Felicia M. Rosenthal, Hendrik Veelken, Andréas Mackensen, Roland Mertelsmann, A. Lindemann and François Lenouvel and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Peter Kulmburg

31 papers receiving 1.1k citations

Peers

Peter Kulmburg
Yashwant M. Deo United States
Kyung‐Soon Park South Korea
D. Mohanraj United States
Ann Mary Joseph United States
Yan Xie China
T Kishida Japan
Thomas M. Rünger United States
Abdul Sattar United Kingdom
Peter Kulmburg
Citations per year, relative to Peter Kulmburg Peter Kulmburg (= 1×) peers Shuwen Wang

Countries citing papers authored by Peter Kulmburg

Since Specialization
Citations

This map shows the geographic impact of Peter Kulmburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kulmburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kulmburg more than expected).

Fields of papers citing papers by Peter Kulmburg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kulmburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kulmburg. The network helps show where Peter Kulmburg may publish in the future.

Co-authorship network of co-authors of Peter Kulmburg

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kulmburg. A scholar is included among the top collaborators of Peter Kulmburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kulmburg. Peter Kulmburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Lei, Peter Kulmburg, Hendrik Veelken, et al.. (2009). Cytokine gene transfer in cancer therapy. Stem Cells. 16(S2). 251–260. 7 indexed citations
2.
Kopp, Jürgen, Peter Kulmburg, Stefan Schultze–Mosgau, et al.. (2004). Accelerated Wound Healing by In vivo Application of Keratinocytes Overexpressing KGF. Molecular Therapy. 10(1). 86–96. 50 indexed citations
3.
Lahn, Michael, Paul Fisch, Regina Kunzmann, et al.. (1999). Pro-Inflammatory and T Cell Inhibitory Cytokines Are Secreted at High Levels in Tumor Cell Cultures of Human Renal Cell Carcinoma. European Urology. 35(1). 70–80. 55 indexed citations
4.
Kulmburg, Peter, Marc R. Radke, & W. Digel. (1998). Lymphotoxin-α is an autocrine growth factor for chronic lymphocytic leukemia B cells. Leukemia. 12(4). 493–498. 10 indexed citations
5.
Prévost‐Blondel, Armelle, Christine Zimmermann, Christine Stemmer, et al.. (1998). Tumor-Infiltrating Lymphocytes Exhibiting High Ex Vivo Cytolytic Activity Fail to Prevent Murine Melanoma Tumor Growth In Vivo. The Journal of Immunology. 161(5). 2187–2194. 139 indexed citations
6.
Mackensen, Andréas, Hendrik Veelken, Michael Lahn, et al.. (1997). Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts. Journal of Molecular Medicine. 75(4). 290–296. 26 indexed citations
7.
Lahn, Michael, Claudia Schmoor, W. A. Dengler, et al.. (1997). Processing of Tumor Tissues for Vaccination with Autologous Tumor Cells. European Surgical Research. 29(4). 292–302. 9 indexed citations
8.
Kulmburg, Peter, et al.. (1997). Cloning and sequence analysis of the immediate promoter region and cDNA of porcine granulocyte colony-stimulating factor. Gene. 197(1-2). 361–365. 6 indexed citations
9.
Veelken, Hendrik, Andréas Mackensen, Michael Lahn, et al.. (1997). A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer. International Journal of Cancer. 70(3). 269–277. 43 indexed citations
10.
Lahn, Michael, Regina Kunzmann, Gottfried Köhler, et al.. (1997). Comparison of Cytogenetics, Cytokine Secretion, and Oncogene Expression in Primary Cultures of Renal Carcinoma Cells. Oncology. 54(5). 429–437. 13 indexed citations
11.
Kulmburg, Peter, Hendrik Veelken, Claudia Schmoor, et al.. (1997). NTS influence on transgene expression from mono- and bicistronic plasmid vectors after lipofection in a human fibroblast cell line. Journal of Molecular Medicine. 75(3). 223–229. 3 indexed citations
12.
Veelken, Hendrik, Daniel Ré, Peter Kulmburg, et al.. (1996). Systematic Evaluation of Chimeric Marker Genes on Dicistronic Transcription Units for Regulated Expression of Transgenes In Vitro and In Vivo. Human Gene Therapy. 7(15). 1827–1836. 13 indexed citations
13.
Rosenthal, Felicia M., Peter Kulmburg, Hendrik Veelken, et al.. (1996). Systemic Hematological Effects of Granulocyte Colony-Stimulating Factor Produced by Irradiated Gene-Transfected Fibroblasts. Human Gene Therapy. 7(17). 2147–2156. 4 indexed citations
14.
Prieschl, Eva E., Peter Kulmburg, & Thomas Baumruker. (1995). The Nomenclature of Chemokines. International Archives of Allergy and Immunology. 107(4). 475–483. 38 indexed citations
15.
Mertelsmann, R, A. Lindemann, Thomas Boehm, et al.. (1995). Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumors. Journal of Molecular Medicine. 73(4). 205–6. 10 indexed citations
16.
Veelken, Hendrik, Andréas Mackensen, Peter Kulmburg, et al.. (1994). Primary Fibroblasts from Human Adults as Target Cells for Ex Vivo Transfection and Gene Therapy. Human Gene Therapy. 5(10). 1203–1210. 38 indexed citations
17.
Lindemann, A., K. Höffken, Michael Flaßhove, et al.. (1994). Serum Cytokine Levels in Cancer Patients Treated with Different Schedules of Ultra-Low-Dose Interleukin-2. Journal of Immunotherapy. 15(3). 225–230. 10 indexed citations
18.
Kulmburg, Peter, Martine Mathieu, Celia E. A. Dowzer, Joseph F. Kelly, & B. Félenbok. (1993). Specific binding sites in the alcR and alcA promoters of the ethanol regulon for the CREA repressor mediating carbon cataboiite repression in Aspergillus nidulans. Molecular Microbiology. 7(6). 847–857. 276 indexed citations
19.
Kulmburg, Peter, et al.. (1992). Immunoglobulin E plus antigen challenge induces a novel intercrine/chemokine in mouse mast cells.. The Journal of Experimental Medicine. 176(6). 1773–1778. 41 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026